|
Thursday, October 7, 2004
|
| 08:00 - 09:00 |
Free Communications Sessions |
|
| |
3 Parallel Sessions
|
|
| |
Chairpersons Session 1:
E.H. Tay, Singapore
J. Dauplat, Clermont-Ferrand, France
|
Hall H |
| |
Chairpersons Session 2:
J-H. Nam, Seoul, South Korea
E. Domingo, Manila, Philippines
|
Hall B |
| |
Chairperson Session 3:
I. Scott, Derby, UK
|
Hall C |
|
09:00 - 10:30 |
State of the Art Sessions
IV, V |
|
| IV. |
GESTATIONAL TROPHOBLASTIC DISEASE
Chairperson:
J. Tidy, Sheffield, UK |
Hall G |
| |
A WORLDWIDE PERSPECTIVE
H.Y.S. Ngan, Hong Kong, China |
|
| |
SURGICAL ISSUES
J. Tidy, Sheffield, UK |
|
| |
RECENT ADVANCES IN PATHOLOGY
M. Wells, Sheffield, UK |
|
| |
TREATMENT OF LOW RISK GTD
R.J. Osborne, North York ON, Canada |
|
| |
TREATMENT OF HIGH RISK GTD
M. J. Seckl, London, UK |
|
| V. |
HORMONE REPLACEMENT THERAPY & GYNAECOLOGICAL
CANCER
Chairperson:
W.T. Creasman, Charleston SC, USA |
Hall A |
| 09:00 |
AN OVERVIEW OF THE RISKS AND BENEFITS OF HRT
W.T. Creasman, Charleston, SC, USA |
|
| 09:20 |
AETIOLOGY OF GYNAECOLOGICAL CANCER RISK ASSOCIATED WITH
HRT
K. Ito, Sendai, Japan |
|
| 09:40 |
HRT AS A RISK FACTOR FOR GYNAECOLOGICAL CANCERS
J. V. Lacey Jr., Bethesda, MD, USA |
|
| 10:00 |
HRT FOR WOMEN WITH A DIAGNOSIS OF GYNAECOLOGICAL CANCER
W.T. Creasman, Charleston SC, USA |
|
| 10:20 |
Discussion |
|
| 11:30 - 12:30 |
Satellite Symposium IV |
Hall A |
| |
EUROPEAN GUIDELINES FOR CERVICAL SCREENING: SAVING
LIVES THROUGH PREVENTION
Sponsored by CYTYC
Chairperson: J. Jordan, Birmingham, UK
|
 |
|
|
| 13:30 - 15:00 |
Interactive Sessions
|
|
| Session 1: |
INTERNATIONAL COLLABORATION IN GYNAECOLOGICAL CANCER
TRIALS
Chairpersons:
E. Trimble, Bethesda MD, USA.
S. Khleif, Amman, Jordan, |
Hall A |
| 13:30 |
BUILDING A NATIONAL RESEARCH NETWORK
K. Fujiwara, Kurashiki-City, Japan
|
| 13:45 |
SETTING STANDARDS FOR SURGERY, CHEMOTHERAPY, AND RADIATION
P.Zola, Torino, Italy
|
| 14:00 |
NEGOTIATING TRIAL DESIGN
G.E.C. Stuart, Vancouver, BC, Canada
|
| 14:15 |
CONTENDING WITH USA REGULATIONS
R.R. Barakat, New York NY, USA
|
| 14:30 |
COPING WITH THE EU DIRECTIVE
N. Reed, Glasgow, Scotland, UK
|
| 14:45 |
GETTING FUNDING FOR INFRASTRUCTURE
M.L. Friedlander, Sydney, Australia
|
| Session 2: |
MANAGEMENT OF BULKY STAGE IB CERVICAL CANCER
Chairperson:
A. Bermudez, Buenos Aires, Argentina |
Hall B |
| 13:30 |
INTRODUCTION
A. Bermudez, Buenos Aires, Argentina |
| 13:40 |
CONCURRENT CHEMORADIATION
R.P. Symonds, Leicester, UK |
| 14:10 |
NEOADJUVANT CHEMOTHERAPY
J. Sardi, Buenos Aires, Argentina |
| 14:40 |
Discussion |
| 14:55 |
FINAL REMARKS
A. Bermudez, Buenos Aires, Argentina |
| Session 3: |
DEBATE - 'THERE IS NO ROLE FOR PRIMARY
SURGERY IN
ADVANCED OVARIAN CANCER'
Chairpersons:
I. Vergote, Leuven, Belgium
P. Rose, Cleveland, OH, USA |
Hall C |
| |
CASES PRESENTATIONS
B-U. Sevin, Jacksonville FL, USA |
|
| Session 4: |
TUMOUR BOARD 2
Chairperson:
B-U. Sevin, Jacksonville FL, USA |
Hall G |
| Session 5: |
QUALITY VS QUANTITY OF LIFE - WHO DECIDES?
Chairpersons:
P. Heintz, Utrecht, The Netherlands
D.A. Fishman, Chicago IL, USA |
Hall H |
| 13:30 |
CONCERNS REGARDING EARLY DETECTION OF CANCER
D. Fishman, New York NY, USA |
| 13:45 |
THE ETHICS OF GENETIC TESTING AND CANCER
To be advised |
| 14:00 |
QUALITY OR QUANTITY OF LIFE: THE DOCTOR'S
POINT OF VIEW
John Curtin, New York NY, USA |
| 14:15 |
THE PATIENT'S PERSPECTIVE
P. Heintz, Utrecht, The Netherlands |
| 14:30 |
Discussion |
| Session 6: |
Selected Poster Presentations
Chairperson:
S. Kehoe, Oxford, UK |
Hall I |
| Top |
|
